⚠Due to planned maintenance you will experience short (<30 min) downtime between 08:00 - 08:30 CET.
Project details:
Project group: | Deliverable D6.1 (2018) | ||||||||
Project group chair: | PaulienEsther Pustjens | ||||||||
Project group members: | - | ||||||||
Project office supporter: | Lydia Foeken and Esther Pustjens | ||||||||
Project description: | Questionnaire to collect regulatory information from EU Member States, to be used in 2019 | ||||||||
Product: | Websites, patents filling, etc. | ||||||||
Project status: |
| ||||||||
Start date: | 2018 | End date: |
|
Project progress:
- Survey ontwikkelen om te checken of regulatory information compleet is (naar EU registries)
Date | Description Action Task | ||
---|---|---|---|
August 21 |
| December 3 | Former WMDA staff member vrijdag 7 december uploaden questionnaire; openbare pagina onder global development pillar information |
Project outcome:
Date | Product | ||||||
---|---|---|---|---|---|---|---|
28-01-2019 |
|
CURRENT QUESTIONNAIRE
...
General information
...
Collection procedure
...
Are procedures in place to minimize microbiological contamination during collection?
...
PROPOSED QUESTIONNAIRE
Introduction
The EU has a common set of standards to ensure the quality and safety of:
- Organs for transplantation, and
- Tissues and cells for human use, including reproductive cells
For EU registries to import cells into a EU Member State, the EU Member States must be able to ensure that cells imported under their licences meet the quality and safety requirements set out in the EU tissues and cells Directive 2004/23/EC and its implementing Directives, including 2006/17/EC and 2006/86/EC.
Instructions for completion
General information
Organisation name:Organisation ION:Country:Year the registry started operations:ProductsCommentsThis organisation provides HPC, Marrow:YES / NOThis organisation provides HPC, Apheresis:YES / NOThis organisation provides HPC, Cord Blood:YES / NOThis organisation provides MNC, Apheresis:YES / NOThis organisation provides NC, Whole Blood:YES / NOThis organisation provides other products:YES / NOPlease specify, other products provided:Number of national HPC products provided in 2017:Number of HPC products exported internationally in 2017:Licences and accreditationsCommentsOrganisation is licensed/accredited by the Competent Authority:YES / NOName of Competent Authority:Date of last inspection:Link to website of Competent Authority:Legal documentation from the Competent Authority that your organisation is allowed to operate as a registry can be provided:YES / NOThe registry is WMDA Qualified or WMDA Accredited:If yes, please specify:
YES / NOThe registry is accredited by any other organisation:
If yes, please fill in the organisation:
YES / NOAffiliated centre informationCommentsHow many affiliated donor centres does the registry work with?How often does the registry audit its donor centres?How many affiliated collection centres does the registry work with?How often does the registry audit its collection centres?How many affiliated cord blood banks does the registry work with?How often does the registry audit its cord blood banks?How many affiliated transplant centres does the registry work with?How often does the registry audit its transplant centres?How many affiliated IDM Testing Laboratories does the registry work with?How often does the registry audit its IDM Testing Laboratories?How many affiliated HLA/other DNA markers testing laboratories does the registry work with?How often does the registry audit its HLA/other DNA markers testing laboratories?The registry would be able to provide a full list of name/addresses of each affiliated and their licence/accreditation status, on request:
Tip: you can upload the full list here and make it available for the WMDA membership
YES / NOThe Cord Blood Banks are FACT-NetCord accredited:
If yes, which cord blood bank(s)?
YES / NOThe registry is able to provide a copy of all the certificates:YES / NOAffiliated centres comply with WMDA Standards and applicable national regulations:YES / NOThe registry has requirements for affiliated centres in addition to WMDA Standards and applicable national regulations:
If yes, please specify these requirements:
YES / NODonor policyAll donors are unpaid volunteers:YES / NOAll donors are informed about donation process and associated risks:YES / NODonors sign a valid informed consent to donate in the presence of a medical doctor/health care personnel/registry staff:YES / NOThe registry has systems in place to protect and control access to donor/patient records:YES / NOThe registry maintains donor anonymity:YES / NOThe registry has detailed donor evaluation and exclusion criteria in place:YES / NOThe registry has donor evaluation and exclusion criteria that do meet or exceed the WMDA guidelines:YES / NOIDM Testing at donor workup (please fill in Yes, On Request, No, Test method)YESOn requestNOTest methodTimeframe before stem cell donation date (for donors) or
Timeframe when the materials sample is taken for testing (for cords)
ALT/AST:
HAV (NAT):
Toxoplasmosis:
Testing
Please indicate whether the following are completed on the donor during the medical examination:
The physical and medical exam at donor work up is performed by a medical doctor:YES / NO
All donor testing (at work up) for infectious disease is performed in a laboratory certified/licensed by a Competent Authority:
YES / NOHLA typing for patient specific request is performed in an appropriately accredited laboratory:
YES / NOSterility testing is performed on the adult donor product:YES / NOSterility testing is performed on the cord blood product:YES / NOScreening questionnaire to exclude communicable disease:YES / NOScreening questionnaire to exclude donors with 'high risk' lifestyles:YES / NODonor reliability identified by a medical doctor:YES / NODonor clearance to donate is confirmed by a medical doctor, following as a minimum the donor exclusion criteria in Annex 1 of EU Directive 2006/17/EC:
The party providing the Cell Product must exclude Donors when:
- They are pregnant;
- They are breastfeeding;
- There is the potential for transmission of inherited conditions;
- There is evidence of any other risk factors for transmissible diseases on the basis of a risk assessment, taking into consideration Donor travel and exposure history and local infectious disease prevalence;
- There is presence on the Donor’s body of physical signs implying a risk of transmissible disease(s);
- There is a history of a disease of unknown aetiology;
- There is a risk of transmission of diseases caused by prions;
- There is systemic infection which is not controlled at the time of donation, including bacterial diseases, systemic viral, fungal or parasitic infections, or significant local infection in the tissues and cells to be donated;
- There is history of chronic, systemic autoimmune disease that could have a detrimental effect on the quality of the Cell Product;
- There is recent history of vaccination with a live attenuated virus where a risk of transmission is considered to exist;
- There is ingestion of, or exposure to, a substance (such as cyanide, lead, mercury, gold) that may be transmitted to recipients in a dose that could endanger their health.
Customs regulations
CommentsAre there any customs regulations to follow, or customs paperwork required, to import cell products to your country? If yes, please specify:
YES / NOAre there any customs regulations to follow, or customs paperwork required, to export cell products from your country? If yes, please specify:
YES / NOAre there any import regulations to follow, or paperwork required, to import cell products to your country? If yes, please specify:
YES / NOAre there any export regulations to follow, or paperwork required, to export cell products from your country? If yes, please specify:
YES / NOReporting of Serious Adverse Events
Please indicate which of the following schemes for reporting Serious Adverse Events relating to either the Donor or the product the Registry participates in:
Mandatory National Reporting SchemeYES / NO
Voluntary National Reporting Scheme
YES / NOWMDA SEAR/SPEAR Reporting Scheme:
YES / NOWill the Registry notify the receiving Registry within 24 hours of receiving information relating to any serious adverse event that could be considered to affect the patient receiving the product?YES / NOQuality management
CommentsDo the registry maintain Standard Operating Procedures (SOPs) for your work?YES / NOWould the registry be willing to provide these to WMDA or another registry upon request?
YES / NOWould the registry be willing to provide WMDA or another registry, on request, with copies of any packaging the HPC product will arrive in?
YES / NOHow many years are donor records retained relating to the medical exam and HPC collection process?